The question of whether kratom is legal is changing quickly. For people in North Carolina who use kratom or high-potency 7-OH products, the answer now depends on which substance and form is being discussed. The DEA has filed two Notices of Intent to temporarily place concentrated 7-hydroxymitragynine (7-OH) and three related compounds into Schedule I of the Controlled Substances Act, with an earliest effective date of August 5, 2026. The 7-OH ban does not make all kratom illegal, but it does signal a major shift that could disrupt supply chains and leave users without access to their usual products.
For professionals and high-functioning individuals in Charlotte and Raleigh who have been quietly relying on kratom or 7-OH products to manage daily stress, pain, or mood, this moment matters. A sudden change in product availability can trigger unplanned withdrawal, which can be uncomfortable and, in some cases, medically significant. Carolina Outpatient Detox offers one of the only specialized kratom detox programs in North Carolina, designed to help clients get ahead of this disruption safely and discreetly.
Current Federal Legal Status of Kratom and 7-OH
At the federal level, kratom itself is not a scheduled substance. The DEA considered scheduling it in 2016 but withdrew that proposal after public pushback. However, the DEA has now moved specifically against concentrated 7-OH, filing Notices of Intent in July 2026 to temporarily schedule it as a Schedule I controlled substance.
Natural kratom leaf and standard kratom powder remain federally unscheduled as of this writing. The new action targets high-potency, concentrated, or synthetic 7-OH products that exceed specific thresholds.
What the 7-OH Ban Means Right Now Versus After It Takes Effect
Right now, concentrated 7-OH products are still being sold in many states, including North Carolina. Once the temporary scheduling order formally publishes, manufacturing, distributing, and possessing covered products will become subject to federal Schedule I restrictions. The transition period is narrow. Retailers may pull products quickly once the order takes effect, and consumers who depend on high-potency 7-OH products could face an abrupt loss of access with little warning.
What North Carolina Kratom Consumers Should Know Right Now
Standard kratom products are not directly targeted by this federal action. However, many popular kratom extracts, shots, and enhanced products on the market today may contain 7-OH concentrations that exceed the new federal threshold. Anyone using these products regularly should assess their level of dependence now, before supply disruptions begin. Acting early can be safer than waiting for an involuntary withdrawal situation.
What is 7-OH and How Is It Different From Kratom?
Kratom and 7-OH are related but not the same. Understanding the distinction helps clarify why regulators are targeting one and not the other, and why concentrated 7-OH products can carry a different risk profile.
Mitragynine vs. 7-Hydroxymitragynine: Potency, Effects, and Sources
Mitragynine is the primary active alkaloid in kratom leaf. 7-hydroxymitragynine (7-OH) is a minor alkaloid found in trace amounts in natural kratom but is more potent at opioid receptors than mitragynine. Because of this potency difference, 7-OH has become the active ingredient in many concentrated kratom extracts and shots sold at gas stations and smoke shops.
7-OH Concentrates and Synthetic Products vs. Natural Kratom Leaf
Natural kratom leaf contains only trace amounts of 7-OH, typically well below the 0.05% threshold identified in the DEA action. Concentrated and synthetic 7-OH products are manufactured to deliver much higher doses, often in small liquid shots or capsules.
These products are pharmacologically distinct from traditional kratom powder and can carry a meaningfully different risk profile for dependence and withdrawal.
Why Regulators Are Targeting High-Potency 7-OH Products
The DEA’s action reflects concern about the opioid-like activity of concentrated 7-OH. Because 7-OH binds to opioid receptors, high-dose products raise concerns about dependence, respiratory depression, and misuse potential.
Regulators are drawing a line between traditional kratom use and newer categories of engineered, high-potency 7-OH products that more closely resemble synthetic opioids in their pharmacological behavior.
The DEA’s Move to Schedule 7-OH
The DEA’s July 2026 regulatory action is one of the most significant moves against kratom-adjacent products in years. Two separate Notices of Intent were published, covering 7-OH and three structurally related compounds.
July 6 Notices of Intent to Ban 7-OH
On July 6, 2026, the DEA published two Notices of Intent in the Federal Register to temporarily place 7-hydroxymitragynine and three related compounds, mitragynine pseudoindoxyl, MGM-15, and MGM-16, into Schedule I of the Controlled Substances Act. A Notice of Intent is a precursor to a formal temporary scheduling order and signals that the DEA has determined these substances pose an imminent public health risk.
Once the formal order takes effect, these substances will be subject to the restrictions associated with Schedule I controlled substances.
The 0.05 Percent or 1 mg Threshold
The DEA’s action includes a specific threshold: products containing more than 0.05% 7-OH by weight, or more than 1.0 mg of 7-OH per article, will be covered by the scheduling order. Natural kratom leaf, which contains only trace 7-OH below this threshold, is explicitly excluded.
This means plain kratom powder and traditional kratom tea are not directly targeted. However, many commercial kratom extracts, shots, and enhanced products may exceed this threshold.
7-OH Ban Timeline: July 6 Publication and August 5 Earliest Effective Date
The Notices of Intent were published July 6, 2026. By statute, a temporary scheduling order cannot take effect fewer than 30 days after publication, placing the earliest possible effective date at August 5, 2026. As of this writing, the formal order has not yet been published but is expected imminently. Consumers and retailers should monitor official federal updates as the scheduling process moves forward.
How Long the 7-OH Ban Could Last: Two-Year Temporary Scheduling With Possible Extension
Temporary scheduling orders under the Controlled Substances Act last two years by default. The DEA has the authority to extend that period by one additional year, meaning the 7-OH ban could remain in effect for up to three years while the agency completes a full scheduling review.
This could create a prolonged period of reduced availability for people who rely on covered 7-OH products.
Is Kratom Legal in North Carolina?
Kratom is currently legal in North Carolina. The state has no statewide ban, and its regulatory environment remains one of the more permissive in the country, although that could change.
Is Kratom Legal in North Carolina? No Statewide Ban, Adult Sales Remain Legal
Kratom is legal to purchase, possess, and use in North Carolina for adults. There is no statewide law currently restricting its sale, establishing an age minimum, or imposing labeling and testing requirements.
Kratom is sold openly at smoke shops, gas stations, and specialty retailers across the state. Plain kratom powder and leaf products can remain legal in North Carolina even after the federal 7-OH scheduling order takes effect, provided they fall outside the federal restrictions.
HB 468 Status: Proposed Age 21 Limits and Testing Rules That Did Not Pass
House Bill 468 was introduced in the North Carolina General Assembly and would have raised the minimum purchase age for kratom to 21 and imposed labeling and testing requirements on kratom products sold in the state. As of this writing, HB 468 has not passed.
North Carolina consumers should be aware that additional regulation could come in future legislative sessions, particularly as federal scrutiny of kratom-adjacent products increases.
Kratom Product Quality in North Carolina: Labeling, Retail Variability, and Safety Concerns
Because North Carolina does not currently have comprehensive statewide testing or labeling requirements for kratom, product quality can vary across retailers. Consumers may have limited ability to verify the actual alkaloid content (including 7-OH levels) of products they purchase.
This variability makes it difficult to assess personal exposure to high-potency 7-OH and underscores the importance of speaking with a medical professional if there is any concern about dependence.
Dependence and Withdrawal Risks as the 7-OH Ban Approaches
For regular users of kratom or 7-OH products, the approaching ban is not just a legal issue. It can also be a health concern. Dependence can develop with consistent use, and an abrupt loss of access can trigger withdrawal.
Signs You May Be Dependent on Kratom or 7-OH and Need Help
Dependence on kratom or 7-OH can develop gradually. Common signs include:
- Needing to use more product to get the same effect
- Feeling anxious, irritable, or physically unwell when doses are missed
- Using kratom or 7-OH first thing in the morning
- Difficulty cutting back despite wanting to
- Spending significant time obtaining or using the product
If any of these patterns sound familiar, speaking with a medical professional before a supply disruption occurs is recommended.
Product Disruptions, Reduced Access, and the Risk of Involuntary Withdrawal
Once the 7-OH scheduling order takes effect, retailers may pull covered products quickly to avoid federal liability. For someone who has been using high-potency 7-OH products daily, this could mean abrupt and unplanned withdrawal without medical support in place.
Kratom and 7-OH withdrawal can include muscle aches, insomnia, anxiety, nausea, and cravings. Symptoms can be significant enough to disrupt work and daily functioning.
How to Plan a Safe Transition Before the 7-OH Ban Changes Supply
The safest approach is to discuss tapering or medically supervised detox with a qualified healthcare professional before supply disruptions occur. This allows an appropriate plan to be developed based on the individual’s health, level of dependence, and treatment needs.
Planning also means having medical support, medication options, and a structured aftercare plan in place rather than trying to manage significant withdrawal alone.
How Carolina Outpatient Detox Can Help
Carolina Outpatient Detox provides a structured, medically supervised option for individuals who are dependent on kratom or 7-OH and want to address their use safely and privately. Explore the full range of outpatient detox programs available to find the right level of care.
One of the Only Specialized Outpatient Kratom Detox Programs in Charlotte and Raleigh
Carolina Outpatient Detox offers one of the only specialized outpatient kratom detox programs in North Carolina, with locations serving Charlotte and Raleigh. The program is designed for individuals who need medical support without inpatient admission.
Clients can continue working and managing daily responsibilities while receiving structured medical support throughout the detox process.
Confidential Assessment, Individualized 21-Day Protocol, and Daily Medical Monitoring
Every client begins with a confidential assessment to evaluate their level of dependence, health history, and treatment goals. From there, an individualized 21-day detox protocol is developed, with daily monitoring by nursing and medical staff to track progress and manage symptoms.
This level of oversight helps ensure that withdrawal is managed appropriately and that complications can be addressed promptly.
Medication-Assisted Support for Kratom Withdrawal With Board-Certified Physician Oversight
When clinically appropriate, Carolina Outpatient Detox provides medication-assisted support to ease withdrawal symptoms and reduce cravings. Protocols are overseen by board-certified physicians with experience in opioid-adjacent withdrawal management.
This approach can help reduce the physical discomfort associated with detox and support successful completion of treatment.
Contact Carolina Outpatient Detox For Help Detoxing From Kratom
The opportunity to plan a safe, medically supervised transition before the 7-OH ban potentially disrupts supply is limited. Acting early means having a clinical team, structured protocol, and appropriate support in place before products become harder to access.
Carolina Outpatient Detox helps individuals address substance use with privacy, convenience, and medical oversight.
Start a Private, Medically Supervised Detox Plan Before the 7-OH Ban Takes Effect
Do not wait for an involuntary withdrawal situation to force your hand. Carolina Outpatient Detox offers confidential, same-day assessments for individuals who are ready to address dependence on kratom or 7-OH.
Contact Carolina Outpatient Detox today to speak with a care coordinator and begin building a plan that fits your needs and daily responsibilities.
7-OH and Kratom Ban FAQs
Does the 7-OH Ban Make Kratom Illegal in North Carolina?
No. The DEA’s temporary scheduling action targets concentrated 7-OH products that exceed 0.05% by weight or 1.0 mg per article. Natural kratom leaf and standard kratom powder, which contain only trace 7-OH below these thresholds, are explicitly excluded from the proposed scheduling action.
Is Kratom Legal in North Carolina Right Now?
Yes. Kratom is currently legal in North Carolina. Adults may purchase and possess kratom, and there is no statewide ban currently in effect. HB 468, which would have added additional regulations, has not passed.
When Does the 7-OH Ban Take Effect and How Long Will It Last?
The earliest effective date for the formal scheduling order is August 5, 2026, following the July 6, 2026 publication of the DEA’s Notices of Intent. Once issued, the temporary order lasts two years, with a possible one-year extension, meaning the scheduling could remain in effect for up to three years.
How Can I Detox From Kratom Discreetly Without Missing Work?
Carolina Outpatient Detox offers a confidential outpatient kratom detox program in Charlotte and Raleigh that allows clients to continue working while receiving daily medical monitoring and support. Same-day admissions are available, and care is provided in a private, professional setting.
What Are the Early Signs of Kratom Withdrawal?
Early signs of kratom withdrawal can include irritability, anxiety, muscle aches, insomnia, sweating, and nausea. Symptoms and their timing vary depending on factors such as the amount and duration of use. Medical supervision can help manage symptoms appropriately.
Dr. Brady Schroer obtained his Bachelor of Science degree in Biopsychology with an emphasis in Chemistry. He then attended Medical School at the Kansas City University of Medicine and Biosciences. After completing medical school, Dr. Schroer completed his general psychiatry residency at a nationally known treatment facility, the Menninger Clinic. Immediately after residency, Dr. Schroer worked in a large medical hospital system caring for geriatric clients, adult inpatient clients, completing consultation liaison evaluations on the medical floors, conducting Electroconvulsive Treatment for clients with severe/refractory depression, and caring for complicated delirium patients in the ICU. During this time, He served as Medical Director and Chief of Psychiatry before moving to Western North Carolina.
